Plasma values for u-PA in children

European Journal of Pediatrics, Supplement

Volumn 158, Issue 3, 1999, Pages

  Zeitler, P ^a   Schuster, V ^b  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b NONE

Author keywords

Fibrinolytic system; Plasminogen; U PA; Urokinase

Indexed keywords

PLASMINOGEN; UROKINASE;

ADOLESCENT; ARTICLE; BLOOD LEVEL; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; HUMAN; HUMAN EXPERIMENT; INFANT; MALE; NORMAL HUMAN; NORMAL VALUE; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL;

EID: 0033372588     PISSN: 09439676     EISSN: None     Source Type: Journal    
DOI: 10.1007/pl00014360     Document Type: Article

References (14)

1. Arnoletti J, Albo D, Granick M, Solomon M, Castiglioni A, Rothman V, Tuszynski G (1995) Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells. Cancer 76:998-1005
2. Bell W (1996) The fibrinolytic system in neoplasia. Semin Thromb Hemostas 22:459-478
3. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, DeVos R, van den Oord JJ, Collen D, Mulligan RC (1994) Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368:419-424
4. Del Vecchio, Stoppeli MP, Carriero MV, Fonti R, Massa O, Li PY, Botti G, Cerra M, D'Aiuto G, Esposito G et al (1993) Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: Comparison with urokinase levels. Cancer Res 53:3198-3206
5. Drew AF, Kaufmann AH, Kombrinck KW, Danton MJ, Daugherty CC, Degen JL, Bugge TH (1998) Ligneous conjunctivitis in plasminogen deficient mice. Blood 91:1616-1624
6. Kolben M, Lopens A, Bläser J, Ulm K, Schmitt M, Schneider KTM, Tschesche H (1996) Proteases and their inhibitors are indicative in gestational age. Eur J Obstet Gynecol 68:59-65
7. Mingers A-M, Heimburger N, Zeitler P, Kreth HW, Schuster V (1997) Homozygous type I plasminogen deficiency. Semin Thromb Hemostas 23:259-269
8. Mingers A-M, Philapitsch A, Zeitler P, Schuster V, Schwarz H-P, Kreth HW (1999) Human homozygous type I plasminogen deficiency and ligneous conjunctivitis. APMIS 107:62-72
9. Nekarda H, Schmitt M, Ulm K, Wenninger A, Vogelsang H, Becker K, Roder JD, Fink U, Siewert JR (1994) Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer. Cancer Res 54:2900-2907
10. Niedbala M, Stein Picarella M (1992) Tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator mediated proteolysis of extracellular matrix and its antagonism by γ-interferon. Blood 79:678-687
11. Plow E, Herren T, Redlitz A, Miles L, Hoover-Plow J (1995) The cell biology of the plasminogen system. FASEB 9:939-945
12. Reverdiau-Moliac P, Gruel Y, Delahousse B, Rupin A, Huart MC, Body G, Leroy J (1991) Comparative study of the fibrinolytic system in human fetuses and in pregnant women. Thromb Res 61:489-499
13. Schäfer B, Maier K, Eickhoff U, Todd R, Kramer M (1994) Plasminogen activation in healing human wounds. Am J Pathol 144:1269-1280
14. Vassalli J-D, Sappino A-P, Belin D (1991) The plasminogen activator/plasmin system. J Clin Invest 88:1067-1072